Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2013-05-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- Radiotherapy
NCT00188214
Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer
NCT02059889
CT Scans in Screening for Lung Cancer in Current and Former Smokers
NCT00625690
Evaluation of the Lung Nodule Sensitivity of Stationary Chest Tomosynthesis in Patients With Known Lung Nodules
NCT02075320
Non-Invasive Biomarkers For Early Detection Of Lung Cancers
NCT01580332
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Conduct a prospective clinical imaging study to quantify the amount of inter- and intra-physician contouring variability on four dimensional (4D) CT, active breathing control (ABC) CT, free breathing CT, and free breathing and ABC cone beam (CB)CT.
II. Quantify the magnitude and distribution of target and organ at risk volume variations between the different imaging modalities.
III. Determine dosimetric changes related to contouring variations for tumor and normal tissue.
OUTLINE:
Patients undergo conventional free breathing CT, 4D CT, ABC CT, ABC CBCT, and free breathing CBCT before undergoing radiation therapy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diagnostic (imaging studies)
Patients undergo conventional free breathing CT, 4D CT, ABC CT, ABC CBCT, and free breathing CBCT before undergoing radiation therapy.
computed tomography
Undergo conventional free breathing CT
4-dimensional computed tomography
Undergo 4D CT
computed tomography
Undergo ABC CT
cone-beam computed tomography
Undergo ABC CBCT
cone-beam computed tomography
Undergo free breathing CBCT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
computed tomography
Undergo conventional free breathing CT
4-dimensional computed tomography
Undergo 4D CT
computed tomography
Undergo ABC CT
cone-beam computed tomography
Undergo ABC CBCT
cone-beam computed tomography
Undergo free breathing CBCT
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with lung cancer visible on CT who are scheduled to receive external beam radiation treatment will be eligible for this study
* Patients must be able to perform ABC procedures
Exclusion Criteria
* No vulnerable populations will be enrolled (prisoners, children, pregnant females or institutionalized individuals)
* Women of childbearing potential will undergo a pregnancy test
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Virginia Commonwealth University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elizabeth Weiss, M.D.
Role: PRINCIPAL_INVESTIGATOR
Virginia Commonwealth University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Virginia Commonwealth University/Massey Cancer Center
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2013-01163
Identifier Type: REGISTRY
Identifier Source: secondary_id
MCC-15032
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.